1190
B. J. George et al. / Tetrahedron 62 (2006) 1182–1192
3.2.2. 1-Benzylideneaminopyrimidine-2,4(1H,3H)-dione
50
0
6. Pale yellow crystals, mp 230 8C (lit.12 mp 219–220 8C),
yield 65%. IR (KBr): 3100, 3000, 2806, 1715, 1667, 1450,
1409, 1370, 1276, 1147, 1090, 957, 862, 824, 751, 690.
LCMS: m/zZ216 (MC1). 1H NMR (DMSO-d6): d 11.59 (s,
1H, NH), 9.06 (s, 1H, CH]N), 8.02 (d, 1H, JZ8.0 Hz),
7.83 (d, 2H, JZ7.6 Hz), 7.52–7.77 (m, 3H), 5.69 (d, 1H, JZ
8.0 Hz). Anal. Calcd for C11H9N3O2 (215.2): C 61.39, H
4.22, N 19.52. Found C 61.48, H 4.39, N 19.52.
TS-III
TS-IV
TS-II
Reac tant
TS-I
-50
-100
-150
-200
-250
-300
P-I + PhCN
P-II + PhCN
3.2.3. 1-Benzylideneamino-2-thioxo-2,3-dihydropyri-
midin-4(3H)-one 7. Yellow crystals, mp 212–214 8C
(lit.12 mp 219–220 8C), yield 70%. IR (KBr): 3027, 2924,
2853, 1671, 1625, 1559, 1380, 1274, 1153, 867, 809, 754,
P + PhCN
1
689. LCMS: m/zZ232 (MC1). H NMR (DMSO-d6): d
11.86 (s, 1H, NH), 8.40 (s, 1H, CH]N), 7.77–7.72 (m, 3H),
Reaction Coordinates
Pathway A involving C=O
Pathway B involving C=N
7.48–7.46 (m, 3H), 6.30 (d, 1H, JZ10.4 Hz).
Figure 4. Free energy profile evaluated at the HF/3-21G* level for
compound 13.
3.2.4.
1-p-Methoxybenzylideneaminopyrimidine-
2,4(1H,3H)-dione 8. Pale yellow crystals, mp 230 8C,
yield 1.10 g (45%). LCMS: m/zZ246 (MC1). IR: 3011,
2922, 2850, 1700 (br), 1606, 1514, 1372, 1256, 1175, 1027,
826. 1H NMR (DMSO-d6): d 11.54 (s, 1H, NH), 8.93 (s, 1H,
CH]N), 7.96 (d, 1H, JZ8.0 Hz), 7.78 (d, 2H, JZ8.4 Hz),
7.08 (d, 2H, JZ8.4 Hz), 5.66 (d, 1H, JZ8.0 Hz), 3.84 (s,
3H, OCH3). 13C NMR (DMSO-d6): d 56.1, 101.3, 115.1,
125.8, 130.8, 144.0, 149.1, 161.4, 162.9, 163.4. Anal. Calcd
for C12H11N3O3 (245.2): C 58.77, H 4.52, N 17.13. Found C
58.90, H 4.58, N 17.14.
T.S.I and T.S.II, respectively. But in this reaction the
formation of PII is more favored than the formation of PI.
The calculated activation energies are K235.1 and
K144.0 kJ/mol for PII and PI respectively. The overall
process is exergonic; with reaction free energy equal to
K255.0 kJ/mol. These results indicate that the formation of
the product is more favored via pathway B than pathway A.
3. Experimental
3.1. General
3.2.5. 1-p-Methoxybenzylideneamino-2-thioxo-2,3-di-
hydropyrimidin-4(3H)-one 9. Yellow crystals, mp
225 8C, yield 1.72 g (66%). LCMS: m/zZ262 (MC1). IR:
3143, 3070, 3025, 2938, 2832, 1685, 1620, 1574, 1509,
1371, 1305, 1347, 1165, 1024, 800. 1H NMR (DMSO-d6): d
11.31 (s, 1H, NH), 8.31 (s, 1H, CH]N), 7.71 (d, 2H, JZ
8.4 Hz), 7.70 (d, 1H, JZ10.5 Hz), 7.03 (d, 2H, JZ8.4 Hz),
6.26 (d, 1H, JZ10.5 Hz), 3.81 (s, 3H, OCH3), 13C NMR
(DMSO-d6): d 56.0, 114.3, 118.2, 127.4, 130.1, 139.2,
156.0, 157.4, 162.0, 162.6. Anal. Calcd for C12H11N3O2S
(261.3): C 55.16, H 4.24, N 16.08. Found C 55.22, H 4.34, N
15.91.
Melting points were determined on a Shimadzu-
Gallenkamp apparatus and are uncorrected. Elemental
analysis was by means of a LECO CHNS-932 Elemental
Analyzer. NMR spectra were measured using a Bruker DPX
400 MHz superconducting spectrometer, and FT-IR
measurements were from a Perkin–Elmer 2000 FT-IR
system. Mass spectrometric analysis was carried out on a
VG-Autospec-Q high performance tri-sector GC/MS/MS,
and the instrument for HPLC was an Agilent 1100 series
LC/MSD with an API-ES/APCI ionization mode.
3.2.6. 3-Benzylideneaminoquinazoline-2,4(1H,3H)-dione
10. White crystals, mp 249 8C (lit.13 mp 243 8C). IR (KBr):
3061, 3005, 2929, 1721, 1666, 1615, 1490, 1445, 1394,
1287, 1169, 935, 823, 755, 683. LCMS: m/zZ266 (MC1).
1H NMR (DMSO-d6): d 11.72 (s, 1H, NH), 8.74 (s, 1H,
CH]N), 7.98 (d, 1H, JZ7.8 Hz), 7.92 (d, 2H, JZ7.6 Hz),
7.70 (t, 1H, JZ7.8 Hz), 7.64 (t, 1H, JZ7.6 Hz), 7.58 (t, 2H,
JZ7.6 Hz), 7.25 (t, 1H, JZ8.0 Hz), 7.24 (d, 1H, JZ
8.0 Hz). 13C NMR (DMSO-d6) d 114.7, 116.0, 123.4, 128.2,
128.9, 129.3, 133.0, 133.3, 135.7, 139.4, 148.4, 159.5,
172.1. Anal. Calcd for C15H11N3O2 (265.3): C 67.92, H
4.18, N 15.84. Found C 67.80, H 4.27, N 15.84.
3.2. Synthesis
3.2.1. General procedure. Compounds 8, 9, 11 and 14 are
new compounds. Compound 8 and 9 were prepared as
described for the synthesis of 6 and 7,12 by reacting the
appropriate semicarbazone or thiosemicarbazone with
methyl 3,3-dimethoxypropanoate in dioxane and
sodium hydride. Compound 10 was prepared as reported.13
Compound 14 was prepared using the same
experimental procedure described for 12 and 13.14 Pyrolysis
1
products were identified by H NMR, LCMS and GC-MS
and compared with authentic samples: benzonitrile,15
uracil,16 2-thiouracil,16 quinazolinone-2,4(1H,3H)-dione,17
2-aminoquinazolin-4(3H)-one,18 dimethylcyanamide,19
acetonitrile,20 Z- and E-cinnamonitrile,21 3-methyl-2H-
[1,2,4]triazino[3,2-b]quinazoline-2,6(1H)-dione,22
3-phenyl-2H-[1,2,4]triazino[3,2-b]quinazoline-2,6(1H)-
dione,22 3-styryl-2H-[1,2,4]triazino[3,2-b]quinazoline-
2,6(1H)-dione.22
3.2.7. 1-Amino-4,6-dimethyl-2-oxo-1,2-dihydro-pyri-
dine-3-carbonitrile. A mixture of cyanoacetohydrazide
(0.99 g, 10 mmol) and acetylacetone (1.00 g, 10 mmol) in
ethanol (10 mL) in the presence of diethylamine (1 mL) was
heated under refluxed for 2 h. The solvent was removed in
vacuum and the residue was cooled to give a solid
precipitate, which was crystallized from ethanol, to give